The Disruptions-Related Tuberculosis Case Finding and Treatment in Indonesia during COVID-19
Downloads
Background: This study aims to find out the disruptions related to the TB new case finding and treatment program during the COVID-19 pandemic in Indonesia. This understanding is needed to conceive effective strategies to face and prevent the issues of TB program implementation in health services and health care. Methods: This review used selected articles conducted in Indonesia, published during the COVID-19 pandemic from March 2020 to July 2022 from ScienceDirect, PubMed, ProQuest, and Google Scholar journal databases. Results: 7187 related studies were identified by the keywords. In the final process, there were 7 studies included in the review. The studies covered 5 provinces mentioned 3 cities and 2 regencies. The disruptions in TB new case finding and treatment health services were affected by participants' knowledge of the differences between TB and COVID-19, family support, family history of COVID-19, comorbidity, double workloads of the health workers, and accessibility of healthcare accommodation. New methods for new case findings and treatment adherence such as scheduled home visits, community-based finding health empowerment, the development of a new invention of eNose-TB, modification of the administration process, and the use of virtual care were implemented to overcome these issues during this pandemic. Conclusion: The majority of tuberculosis issues during COVID-19 were related to social determinants. The health empowerment that involved community and several modifications to health services were applied to healthcare as resolutions besides preserving the achievement of new case findings and treatment programs.
Alene, K. A., Wangdi, K. and Clements, A. C. A. (2020) ‘Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview’, Tropical Medicine and Infectious Disease, 3(123), pp. 1–8.
Appulembang, I. et al. (2021) ‘Factors Affecting Treatment Compliance In Tb Patients (Tuberculosis) During Pandemic Covid-19 At Labuang Baji Makassar Hospital’, International Journal of Health and Pharmaceutical (IJHP), 1(1), pp. 11–16. doi: 10.51601/ijhp.v1i1.3.
Arora, P., Mehta, D. and Ha, J. (2022) ‘Impact of telehealth on health care resource utilization during the COVID-19 pandemic’, Journal of Comparative Effectiveness Research, 11(5), pp. 301–309. doi: 10.2217/cer-2021-0242.
Aznar, M. L. et al. (2020) ‘Impact of the COVID-19 pandemic on tuberculosis management in Spain’, International Journal of Infectious Diseases, 108(January), pp. 300–305.
Bastani, P. et al. (2021) ‘Factors influencing access and utilization of health services among older people during the COVID − 19 pandemic: a scoping review’, Archives of Public Health, 79(1), pp. 1–11. doi: 10.1186/s13690-021-00719-9.
CASP, C. A. S. P. (2018) ‘CASP Qualitative Checklist’, CASP Online, (2018), p. 1.
Chakaya, J. et al. (2021) ‘Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts’, International Journal of Infectious Diseases, (xxxx), pp. 4–9. doi: 10.1016/j.ijid.2021.02.107.
Chan, G. et al. (2021) ‘Adapting active case-finding for TB during the COVID-19 pandemic in Yogyakarta, Indonesia’, Public Health Action, 11(2), pp. 41–49.
Djalante, R. et al. (2020) ‘Review and analysis of current responses to COVID-19 in Indonesia: Period of January to March 2020’, Progress in Disaster Science, 6. doi: 10.1016/j.pdisas.2020.100091.
Eberly, L. A. et al. (2020) ‘Patient Characteristics Associated with Telemedicine Access for Primary and Specialty Ambulatory Care during the COVID-19 Pandemic’, JAMA Network Open, 3(12), pp. 1–12. doi: 10.1001/jamanetworkopen.2020.31640.
Elm, E. von et al. (2014) ‘The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies’, International Journal of Surgery, 12(12), pp. 1495–1499. doi: 10.1016/j.ijsu.2014.07.013.
Jain, V. K. et al. (2020) ‘Tuberculosis in the era of COVID-19 in India’, Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(5), pp. 1439–1443. doi: 10.1016/j.dsx.2020.07.034.
Kemenkes, R. (2021) Situasi Tuberkulosis Indonesia Tahun 2021, Data TBC pada tanggal 4 Oktober 2021.
Mading, M. et al. (2021) ‘Pengendalian Tuberkulosis pada Masa Pandemi Covid-19 di Puskesmas Elopada Kabupaten Sumba Barat Daya Propinsi Nusa Tenggara Timur Tahun 2020’, Buletin Penelitian Kesehatan, 49(2), pp. 135–144.
Malik, A. A. et al. (2020) ‘Tuberculosis control and care in the era of COVID-19’, Health Policy and Planning, 35(8), pp. 1130–1132. doi: 10.1093/heapol/czaa109.
McQuaid, C. F. et al. (2021) ‘The impact of COVID-19 on TB: A review of the data’, International Journal of Tuberculosis and Lung Disease, 25(6), pp. 436–446. doi: 10.5588/ijtld.21.0148.
Migliori, G. B. (2022) ‘Tuberculosis and COVID-19 co-infection: description of the global cohort’, European Respiratory Journal, 59(3), p. 2102538. doi: 10.1183/13993003.02538-2021.
Min, J. et al. (2022) ‘Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study’, Journal of Korean Medical Science, 37(3), pp. 1–10. doi: 10.3346/JKMS.2022.37.E20.
Napitupulu, T. F. and Prasetyo, S. (2021) ‘Akses Pelayanan Pengobatan Tuberkulosis Pada Masa Pandemi Covid-19 Di Puskesmas Abadijaya Kota Depok Tahun 2021’, NERSMID : Jurnal Keperawatan dan Kebidanan, 4(2), pp. 207–226.
Odume, B. et al. (2020) ‘Impact of COVID-19 on TB active case finding in Nigeria’, Public Health Action, 10(4), pp. 157–162.
Page, M. J. et al. (2021) ‘The PRISMA 2020 statement: An updated guideline for reporting systematic reviews’, The BMJ, 372. doi: 10.1136/bmj.n71.
Rezkiani, A. akifah, Batara, A. S. and Amelia, A. R. (2021) ‘Implementasi Kebijakan Penanggulanan Tuberkulosis Pada Masa Pandemi Covid-19’, Window of Public Health Journal, 2(3), pp. 1318–1330.
Rodrigues, I. et al. (2022) ‘Impact of the COVID-19 pandemic on tuberculosis services’, Pulmonology, 15(4), pp. 1–10. doi: 10.1016/j.pulmoe.2022.01.015.
Saktiawati, A. M. I. et al. (2021) ‘eNose-TB: A trial study protocol of electronic nose for tuberculosis screening in Indonesia’, PLoS ONE, 16(4 April), pp. 1–15. doi: 10.1371/journal.pone.0249689.
Santos, F. L. Dos et al. (2021) ‘Patients’ perceptions regarding multidrugresistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study’, PLoS ONE, 16(4 April), pp. 1–19. doi: 10.1371/journal.pone.0249822.
Sanyaolu, A. et al. (2020) ‘Comorbidity and its Impact on Patients with COVID-19’, SN Comprehensive Clinical Medicine, 2, pp. 1069–1076. doi: 10.1183/13993003.01227-2020.
Stephenson, E. et al. (2021) ‘Changes in the top 25 reasons for primary care visits during the COVID-19 pandemic in a high-COVID region of Canada’, PLoS ONE, 16(8 August), pp. 1–15. doi: 10.1371/journal.pone.0255992.
Syahridha, S. et al. (2021) ‘Associated factors of the results of pulmonary tuberculosis treatment during the covid-19 pandemic in makassar city’, Open Access Macedonian Journal of Medical Sciences, 9, pp. 1001–1005. doi: 10.3889/oamjms.2021.6742.
Visca, D. et al. (2020) ‘Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects’, Pulmonology, (January), pp. 151–165.
WHO (2019) Consolidated Guidelines on Tuberculosis Treatment, Who.
WHO (2021) Global Tuberculosis Report 2021. Geneva: World Health Organization.
Zimmer, A. J. et al. (2021) ‘Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective’, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 24, p. 100248. doi: 10.1016/j.jctube.2021.100248.
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
![Lisensi Creative Commons](https://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
In order to be accepted and published by Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education, Author(s) who submit an article should complete all the review process. The copyright of received articles assigned to the Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education,and Department of Health Promotion and Behavior Science, Universitas Airlangga as publishers of the journal. The intended copyright includes the rights to publish articles in various forms (including reprints).
Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education's website. Authors are allowed to use their works for any purposes deemed necessary without written permission from Jurnal Promkes: The Indonesian Journal of Health Promotion and Health EducationS and/or Department of Health Promotion and Behavior Science, Universitas Airlangga with an acknowledgement of initial publication in this journal.
The Editorial Team of Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education and Department of Health Promotion and Behavior Sciences strive to ensure that no errors occur in the articles that have been published, both data errors and statements in the article.
Users of this website will be licensed to use materials from this website following the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. No fees charged. Please use the materials accordingly.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.